Hepcidin: regulation of the master iron regulator
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Iron, an essential nutrient, is required for many diverse biological processes. The absence of a defined pathway to excrete excess iron makes it essential for the body to regulate the amount of iron absorbed; a deficiency could lead to iron deficiency and an excess to iron overload and associated disorders such as anaemia and haemochromatosis respectively. This regulation is mediated by the iron-regulatory hormone hepcidin. Hepcidin binds to the only known iron export protein, ferroportin (FPN), inducing its internalization and degradation, thus limiting the amount of iron released into the blood. The major factors that are implicated in hepcidin regulation include iron stores, hypoxia, inflammation and erythropoiesis. The present review summarizes our present knowledge about the molecular mechanisms and signalling pathways contributing to hepcidin regulation by these factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo, the expression of Hamp in the hepatocyte is governed by stimulatory (iron overload and inflammation) and inhibitory factors (erythropoietic ERFE and hypoxia), the net effect of these factors defining the Hamp level in the organism (31).”
From Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection (2017) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Research works printed but not linked: 2
- Mayeur C. Lohmeyer L.K. Leyton P. Kao S.M. Pappas A.E. Kolodziej S.A. Spagnolli E. Yu B. Galdos R.L. Yu P.B. The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6 Blood 2014 123 2261 2268 10.1182/blood-2013-02-480095 24501215 PMC3975261 · DOI · Paper page
- Latour C. Kautz L. Besson-Fournier C. Island M.L. Canonne-Hergaux F. Loreal O. Ganz T. Coppin H. Roth M.P. Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin Hepatology 2014 59 683 694 10.1002/hep.26648 23907767 · DOI · Paper page
Cited by
Items 101–200 of 229
Influence of mitochondrial and systemic iron levels in heart failure pathology
Lupu, M., Tudor, D. V., & Filip, G. A. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09788-z · Cited by 13
Mansour, G. K., Hajjar, A. W., & Sajid, M. R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1726337 · Cited by 15
“This regulatory mechanism represents a sophisticated homeostatic system that responds to multiple physiological stimuli, including iron status, inflammation, and demand for erythropoiesis (10).”
Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism
Horváth, A., Tamási, K., Pap, R., Jánosa, G., & Pandur, E. (2025) · Nutrients · doi:10.3390/nu18010109 · Cited by 16
“This complex then translocates to the nucleus, resulting in hepcidin transcription [76,77].”
Sato, M., Miyanishi, K., Tanaka, S., Sakurada, A., Sakamoto, H., Kawano, Y., Takada, K., Kobune, M., & Kato, J. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/2154361 · Cited by 14
“Hepcidin affects macrophages, Hela cells, or human embryonic kidney cells, so that they regulate iron efflux and storage and the duodenum so that it inhibits iron absorption [7–9].”
Changes in serum hepcidin according to thyrometabolic status in patients with Graves’ disease
Krygier, A., Szczepanek‐Parulska, E., Filipowicz, D., & Ruchała, M. A. (2020) · Endocrine Connections · doi:10.1530/ec-20-0017 · Cited by 14
Kwiatkowska, K., Winiarska‐Mieczan, A., & Kwiecień, M. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1171-3 · Cited by 12
“Low concentration of hepcidin in blood leads to increased activity of ferroportin, which is manifested in an increased level of iron in blood, high degree of transferrin saturation and excessive build-up of iron in the liver and other tissues, including bones [29, 30].”
Ma, Q., Hu, J., Yang, W. Q., & Hou, Y. (2020) · Japanese Journal of Radiology · doi:10.1007/s11604-020-00921-9 · Cited by 11
Njomen, E., Vanecek, A. S., Lansdell, T. A., Yang, Y.-T., Schall, P. Z., Harris, C. M., Bernard, M. P., Isaac, D., Alkharabsheh, O. A., Al-Janadi, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10050938 · Cited by 11
“Plasma iron levels are mediated by hepcidin, which, in broad terms, acts as a negative regulator of iron in circulation by increasing endocytosis of ferroportin, increasing iron in cells and decreasing iron in the plasma [60,61].”
BackgroundKuhn, D. E., O’Brien, K. M., & Crockett, E. L. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00188.2016 · Cited by 12
“Hepcidin is responsible for lysosomal internalization and degradation of FPN, thus inhibiting FPN-mediated release of Fe from enterocytes, macrophages, and hepatocytes (43, 47).”
BackgroundGuo, X., Huang, L., Gong, S., Li, M., Wang, W., Chen, J., Zhang, Y.-D., Lu, X., Chen, X., Luo, L., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04238-w · Cited by 12
“Ferroportin 1(Fpn1), the sole iron exporter in vertebrate species, is a transmembrane protein that exports cellular iron to maintain iron homeostasis [54, 55].”
MyD88 Regulates the Expression of SMAD4 and the Iron Regulatory Hormone Hepcidin
Samba-Mondonga, M., Calvé, A., Mallette, F. A., & Santos, M. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00105 · Cited by 10
“Since Ferroportin 1 is expressed on duodenal enterocytes absorbing dietary iron and on macrophages in liver and spleen, high hepcidin levels leads to the suppression of intestinal iron absorption and the accumulation of iron in macrophages (Rishi et al., 2015).”
BackgroundKiełbik, P., Jończy, A., Kaszewski, J., Gralak, M. A., Rosowska, J., Sapierzyński, R. A., Witkowski, B. S., Wachnicki, Ł., Ławniczak‐Jabłońska, K., Kuźmiuk, P., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14090859 · Cited by 10
Iron Overload in anHFEHeterozygous Carrier: A Case Report and Literature Review
Turbiville, D., Du, X., Yo, J., Jana, B., & Dong, J. (2018) · Laboratory Medicine · doi:10.1093/labmed/lmy065 · Cited by 11
Serum Hepcidin Is Increased in ANCA-Associated Vasculitis and Correlates With Activity Markers
Přikryl, P., Hrušková, Z., Konopásek, P., Hladinová, Z., Tesař, V., & Vokurka, M. (2018) · Physiological Research · doi:10.33549/physiolres.933765 · Cited by 11
Epigenetic Regulation of Ferroportin in Primary Cultures of the Rat Blood-Brain Barrier
Helgudóttir, S. S., Routhe, L. G., Burkhart, A., Jønsson, K., Pedersen, I. S., Lichota, J., & Moos, T. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01953-y · Cited by 10
The clinical value of plasma hepcidin levels in predicting bacterial infections in febrile children
Yan, J., Cai, X.-Y., & Huang, Y. (2018) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2018.09.001 · Cited by 9
Fernández‐Ruiz, M., Parra, P., Ruiz‐Merlo, T., López‐Medrano, F., Juan, R. S., Polanco, N., González, E., Andrés, A., & Aguado, J. M. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12807 · Cited by 9
Raha‐Chowdhury, R., Raha, A. A., Henderson, J. W., Ghaffari, S. D., Grigorova, M., Beresford‐Webb, J., Allinson, K. S. J., Chakraborty, S., Holland, A. J., & Zaman, S. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132909 · Cited by 9
“Hepcidin synthesis by hepatocytes is stimulated when body iron levels increase during systemic inflammation and is usually suppressed by hypoxia and increased erythroid activity [48,49].”
BackgroundAMP‐activated protein kinase α1 phosphorylates PHD2 to maintain systemic iron homeostasis
Wang, C., Zhang, W., Xu, W., Liu, Z., & Huang, K. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.854 · Cited by 11
Pino, J. M. V., Silva, V. F., Mônico‐Neto, M., Seva, D. C., Kato, M. Y., Alves, J., Pereira, G. C., Antunes, H. K. M., Galvão, T. D., Bitterncourt, L. R. A., et al. (2023) · International Journal of Endocrinology · doi:10.1155/2023/7625720 · Cited by 10
“Hepcidin, in turn, reduces the ferroportin levels and, consequently, the iron recycling and absorption, causing functional iron defciency [40].”
BackgroundGluconeogenic signals regulate hepcidin gene expression via a CRBN-KLF15 axis
Jo, J.-R., Lee, S., An, S., Nedumaran, B., Ghosh, S., Park, K., & Kim, Y. D. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.4.215 · Cited by 9
Ribeiro, S., Garrido, P., Fernandes, J. C., Rocha, S., Rocha‐Pereira, P., Costa, E. M., Belo, L., Reis, F., & Santos‐Silva, A. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.04.008 · Cited by 10
“BMP6 mRNA levels can be regulated by liver iron overload [12], as well as by the TfR2/HJV complex [25], even in the absence of iron overload.”
Iron, Copper, and Selenium: Cancer's Thing for Redox Bling
Terzi, E. M., & Possemato, R. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041545 · Cited by 10
Effects of iron overload in human joint tissue explant cultures and animal models
Prasadam, I., Schrobback, K., Kranz-Rudolph, B., Fischer, N., Sonar, Y., Sun, A. R., Secondes, E. S., Klein, T. J., Crawford, R., Subramaniam, V. N., et al. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02495-9 · Cited by 8
“Furthermore, the hypoxic conditions within the deeper layers of the cartilage explants may further suppress HAMP expression, as hypoxia has been reported to negatively regulate this gene [47].”
Self-citationLee, S., Houstis, N. E., Cunningham, T. F., Brooks, L. C., Chen, K., Slocum, C. L., Ostrom, K. F., Birchenough, C., Moore, E., Tattersfield, H., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.02.024 · Cited by 8
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling
Formica, V., Riondino, S., Morelli, C., Guerriero, S., D’Amore, F., Grazia, A. D., Blanco, G. D. V., Sica, G. S., Arkenau, H., Monteleone, G., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02266-2 · Cited by 8
“Another mechanism of high iron and low Hepcidin observed in HCC involves the bone morphogenetic protein 6—small mother against decapentaplegic (BMP6-SMAD) pathway, that is the signal physiologically responsible for hepatic Hepcidin synthesis in response to iron excess [130].”
BackgroundBarton, J. C., Barton, J. C., & Acton, R. T. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02763-x · Cited by 10
“HFE, a non-classical class I major histocompatibility complex protein, is an upstream regulator of hepcidin and thus of iron homeostasis [6].”
BackgroundAngmo, S., Rana, S., Yadav, K., Sandhir, R., & Singhal, N. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-35992-2 · Cited by 8
Kim, H.-B., Jun, J. H., Shim, J., Oh, J. E., Lee, C., & Kwak, Y. L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4357756 · Cited by 8
“Hepcidin is upregulated by an increase in iron stores in the body and inflammatory conditions and is downregulated by erythropoiesis [4, 5].”
BackgroundInfluentialThe ‘Checkmate’ for Iron Between Human Host and Invading Bacteria: Chess Game Analogy
Kalidasan, V., Joseph, N. M. S., Kumar, S. S., Hamat, R. A., & Neela, V. K. (2018) · Indian Journal of Microbiology · doi:10.1007/s12088-018-0740-2 · Cited by 9
Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1
Chen, O. C. W., Siebel, S., Colaço, A., Nicoli, E., Platt, N., Shepherd, D., Newman, S. K., Armitage, A. E., Farhat, N. Y., Seligmann, G., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17261.1 · Cited by 7
Serum Iron Overload Activates the SMAD Pathway and Hepcidin Expression of Hepatocytes via SMURF1
Zhang, N., Yang, P., Li, Y., Ouyang, Q., Hou, F., Zhu, G., Zhang, B., Huang, J., Jia, J., & Xu, A. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00440 · Cited by 14
Perinatal Factors Affecting Serum Hepcidin Levels in Low-Birth-Weight Infants
Ichinomiya, K., Maruyama, K., Inoue, T., Koizumi, A., Inoue, F., Fukuda, K., Yamazaki, Y., & Arakawa, H. (2017) · Neonatology · doi:10.1159/000473871 · Cited by 8
Iron Overload in Renal Transplant Patients: The Role of Hepcidin and Erythropoietin
Bilar, J. M., Pereira, P. D. S. F., Amaral, A. C., de Carvalho‐Filho, R. J., Silva, I., Medina-Pestana, J. O., & Ferraz, M. L. G. (2020) · Transplantation Proceedings · doi:10.1016/j.transproceed.2019.10.020 · Cited by 7
Wu, Z., Yao, T., Han, Z., Wang, Z., Liu, B., Lu, M., Zheng, J., & Shen, N. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70422 · Cited by 6
Rishi, G., Secondes, E. S., Wallace, D. F., & Subramaniam, V. N. (2020) · Bioscience Reports · doi:10.1042/bsr20191499 · Cited by 6
Self-citationHigh-iron consumption decreases copper accumulation and colon length, and alters serum lipids
Lee, J., Lee, H., Jang, H., Lee, J., & Ha, J. (2024) · Applied Biological Chemistry · doi:10.1186/s13765-024-00861-2 · Cited by 6
“However, in the presence of excess iron, hepatic hepcidin levels increase, further inhibiting intestinal iron absorption and/or macrophage iron recycling by suppressing the expression of ferroportin 1, an iron exporter [11, 12].”
BackgroundUguen, K., Scotet, V., Ka, C., Gourlaouen, I., L’Hostis, C., Mérour, M.-C., Cuppens, T., Férec, C., & Gac, G. L. (2017) · American Journal of Hematology · doi:10.1002/ajh.24912 · Cited by 6
Kong, W., Cui, Y., Fu, Y., Lei, Y., Ci, Y., Bao, Y., Zhao, S., Xie, L., Chang, Y., & Zhao, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26715 · Cited by 7
“Similarly, the regulation of hepcidin expression is dependent on various factors in addition to the STAT3 pathway.(40) The bone morphogenetic protein (BMP) and small mothers against decapentaplegic (SMAD) pathway has a central role in the regulation of hepcidin in response to body iron levels.”
BackgroundStančić, A., Markelic, M. B., Savic, N., Veličković, K., Martinović, V., Gudelj, A., Velickovic, D., Grigorov, I., & Otašević, V. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1673012 · Cited by 5
“In addition, increased iron storage in hepatocytes and cells of the reticuloendothelial system has been shown to lead to anemia in patients with T1D (65 – 67).”
Serum hepcidin concentrations in relation to iron status in children with type 1 diabetes
Vreugdenhil, M., Akkermans, M. D., van Swelm, R. P. L., Laarakkers, C. M., Houdijk, E. C. A. M., Bakker, B., Boers, A. C.-D., van der Kaay, D. C. M., de Vries, M. C., Woltering, M. C., et al. (2020) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2020.1820650 · Cited by 5
“Second, various stimuli with opposing effects on hepcidin synthesis may very well act at the same time.(8) For example, in our main-analysis group, it might be that in the FID-group, a combination of both AID and FID exists.”
BackgroundDysregulation of ferroportin gene expression in β0-thalassemia/Hb E disease
Sornjai, W., Jaratsittisin, J., Khungwanmaythawee, K., Svasti, S., Fucharoen, S., Lithanatudom, P., & Smith, D. R. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2572-z · Cited by 5
“To ensure the availability of suitable amounts of iron for erythropoiesis, erythroblasts secrete factors that inhibit production of the peptide hormone hepcidin [7].”
BackgroundChmielewska, A., Chmielewski, G., Domellöf, M., Lewandowski, Z., & Szajewska, H. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009441 · Cited by 7
Yu, W.-H., Li, X., & Yuan, F. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i23.6048 · Cited by 5
Kondo, S., Ferdousi, F., Yamauchi, K., Suidasari, S., Yokozawa, M., Harrabi, M. M., Tominaga, K., & Isoda, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16752 · Cited by 5
Chronic Heart Failure: Clinical Implications of Iron Homeostasis Disturbances Revisited
Suciadi, L. P., Henrina, J., Putra, I. C. S., Cahyadi, I., & Gunawan, H. F. H. (2022) · Cureus · doi:10.7759/cureus.21224 · Cited by 5
“Hepcidin, a peptide that regulates systemic iron metabolism, is a negative regulator that restricts gastrointestinal iron absorption and prevents its release from the reticuloendothelial system [23-24,28-29].”
BackgroundZhao, M., Wang, Y., Yang, J., Wang, Y., Feng, Y., Chen, L., Shao, Z., Wang, H., & Xing, L. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2157475 · Cited by 5
“liver and the reticuloendothelial system [26,27].”
Badi, S. A., Malek, A., Seyedi, S. A., Bereimipour, A., Irian, S., Shojaie, S., Sohouli, M. H., Rohani, P., Masotti, A., Khatami, S., et al. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04007-2 · Cited by 4
“The regulation of iron metabolism is crucial to the host as iron is an essential element in maintaining the survival of organisms and is potentially harmful at both overload and deficient levels (Rishi et al. 2015 ).”
Biernat, M. M., Camp, O. G., Moussa, D. N., Awonuga, A. O., & Abu‐Soud, H. M. (2025) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2025.112927 · Cited by 4
Hepcidin: An emerging hormone in iron homeostasis: A review
Karoriya, A. K., Jain, A., Kumar, R., & Shakkarpude, J. (2021) · International Journal of Chemical Studies · doi:10.22271/chemi.2021.v9.i1ai.11600 · Cited by 4
El-Gharbawi, N., Shaheen, I. A. E.-M., Hamdy, M. M., Elgawhary, S. M., Samir, M., Hanna, B. M., Ali, E. Y., & Youssef, E. A. (2022) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-022-01580-8 · Cited by 4
Maltaneri, R. E., Chamorro, M. E., Gionco, S., Nesse, A. B., & Vittori, D. C. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119800 · Cited by 5
COVID-19 and Iron Metabolism: Traditional Review
Yılmaz, N., Eren, E., ÖZ, C., Kalayci, Z., & Saribek, F. (2021) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2021-81574 · Cited by 5
Hepcidin inhibition improves iron homeostasis in ferrous sulfate and LPS treatment model in mice
PATEL, V. G., Joharapurkar, A. A., Kshirsagar, S. G., Patel, M. S., Patel, H., Savsani, H. H., & Jain, M. R. (2021) · Drug Research · doi:10.1055/a-1542-8531 · Cited by 5
“Hepcidin is also regulated by bone morphogenic protein receptor (BMP) type 1, which is also known as activin receptors (ALK) receptors [3].”
BackgroundInfluentialTracking hepcidin level in induced type 2 diabetic rats and how Empagliflozin affects its level
Ali, R. B., Ahmed, M. H., Ibrahim, H. K., & Mahmood, H. S. (2022) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2022.965 · Cited by 5
Hepcidin and iron metabolism in non-diabetic obese and type 2 diabetic rats
Chen, Y., Hui-qing, Y., Liu, H., Xiu, L., & Peng, X.-Y. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1517-z · Cited by 4
Gaur, P., Saini, S., Ray, K., Kishore, K., Asanbekovna, K. N., Akunov, A., Maripov, A., Sharma, Y. K., Sharma, S. K., Kumar, B., et al. (2020) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2020.10.001 · Cited by 4
Factors related to mean corpuscular volume in HFE p.C282Y homozygotes
Barton, J. C., Barton, J. C., & Acton, R. T. (2024) · eJHaem · doi:10.1002/jha2.1063 · Cited by 3
Kluknavský, M., Mičurová, A., Škrátek, M., Bališ, P., Okuliarová, M., Maňka, J., & Bernátová, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051475 · Cited by 4
“It is known that the hepatic release of hepcidin is regulated predominantly by intrahepatic iron concentration [50].”
BackgroundTransferrin Receptor 2 in Canine Testicular Tumors: An Emerging Key Role in Seminomas
Leandri, R., Buonocore, S., & Power, K. (2025) · Animals · doi:10.3390/ani15020264 · Cited by 4
Inflammation can increase hepcidin in HFE‐hereditary hemochromatosis
Moris, W., Verhaegh, P. L. M., Masclee, A., Swinkels, D. W., Laarakkers, C. M., Koek, G. H., & van Deursen, C. T. B. M. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4114 · Cited by 3
Serum erythroferrone levels during the first month of life in premature infants
Lenhartová, N., Ochiai, M., Sawano, T., Yasuoka, K., Fujiyoshi, J., Inoue, H., & Ohga, S. (2021) · Journal of Perinatology · doi:10.1038/s41372-021-01184-6 · Cited by 4
Iron supplementation ameliorates aloin-induced iron deficiency anemia in rats
Abdel-Moniem, M. M., Hassan, A. M., Said, M. M., & Esmat, A. Y. (2022) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2021.104740 · Cited by 4
Barton, J. C., Barton, J. C., & Acton, R. T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271973 · Cited by 3
“1) [1] that encodes HFE, a negative upstream regulator of hepcidin [2], and two common non-ancestral HFE alleles p.C282Y (c.845G > A; rs1800562) and p.H63D (c.187C > G; rs1799545) were discovered in referred white patients with hemochromatosis and iron overload (IO) in 1996 [1].”
Next generation sequencing to identify iron status and individualise blood donors' experience.
Jacko, G., Sivakaanthan, A., Obeysekera, M., Welvaert, M., Viennet, E., Hyland, C. A., Tung, J., Perros, A. J., Flower, R. L., & Roulis, E. V. (2023) · Blood transfusion · doi:10.2450/bloodtransfus.499 · Cited by 4
Kawabata, H., Miyazawa, N., Matsuda, Y., Satobe, M., Mizogami, Y., Kuriyama, Y., Sakai, T., Mori, M., & Sasa, M. (2024) · International Journal of Hematology · doi:10.1007/s12185-024-03720-4 · Cited by 3
“[24].”
Detlie, T. E., Burisch, J. M., Jahnsen, J., Bonderup, O. K., Hellström, P. M., Lindgren, S. C., & Frigstad, S. O. (2025) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2025.2487907 · Cited by 3
“iron exists in two redox states (Fe 2+ and Fe 3+ ), which increases its utility as a cofactor in enzymes [19,20]. in the Fenton reaction, iron is oxidised by hydrogen peroxide to generate free radicals such as hydroxyl and superoxide iron, which form a part of the collective radical oxygen species.”
Sasaki, M., Ueda, K., Fukuda, T., Tanaka, N., Shimizu, H., & Kubota, K. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.061 · Cited by 3
Mehta, K. J., Busbridge, M., Patel, V. B., & Farnaud, S. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03716-8 · Cited by 3
Secondes, E. S., Wallace, D. F., Rishi, G., McLaren, G. D., McLaren, C. E., Chen, W., Ramm, L. E., Powell, L. W., Ramm, G. A., Barton, J. C., et al. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102463 · Cited by 3
“Introduction Dysregulation of systemic iron homeostasis leads to either an increase or a decrease in body iron levels [1].”
BackgroundSelf-citationYu, W.-H., Li, X., & Yuan, F. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i23.6042 · Cited by 3
IgG subclass levels in referred hemochromatosis probands with HFE p.C282Y/p.C282Y
Barton, J. C., Barton, J. C., Bertoli, L. F., & Acton, R. T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302817 · Cited by 2
Hepcidin: A multifaceted hormone in iron homeostasis and tumor biology
Liu, X., Zhang, X., Fan, Y., & Tan, K. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.10.003 · Cited by 3
Barton, J. C., Barton, J. C., & Acton, R. T. (2025) · eJHaem · doi:10.1002/jha2.70092 · Cited by 2
NAG-1/GDF15 modulates hepcidin expression through STAT3 and SMAD pathways
Lertpatipanpong, P., Krisanapun, C., Boonruang, K., Jung, Y. J., & Baek, S. J. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110724 · Cited by 2
Mohamed, S. M. Y., Kelini, K. I. S., Mahmoud, S. S., El-Hady, A. A. A., Ahmed, K. A. F., Mohamed, M. M., & Ismail, A. M. A. (2025) · SPORT TK-Revista EuroAmericana de Ciencias del Deporte · doi:10.6018/sportk.694821 · Cited by 2
Al-Helo, H., Desai, S. A., Varma, T., Garg, P., & Shahiwala, A. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100220 · Cited by 2
Non-apoptotic Regulated Cell Death Mechanisms in Sepsis and their Therapeutic Potential
Mitre, A. O., Neag, M. A., Bâldea, I., Filip, G. A., Mitre, B., & Pârvu, A. E. (2026) · Inflammation · doi:10.1007/s10753-025-02356-8 · Cited by 3
“Hepcidin regulates FPN levels by binding to FPN and causing its degradation [74 ].”
Influence of Physical Activity on the Regulation of Iron Metabolism
Zaitseva, I. P., Tinkov, A. A., & Skalny, A. V. (2018) · Human Physiology · doi:10.1134/s0362119718050158 · Cited by 2
Iron Status of Newborns and Umbilical Cord Blood Hepcidin Levels in Gender Differences
Santosa, Q., Soemantri, A., Hadisaputro, S., & Soejoenoes, A. (2020) · Jurnal Kedokteran Brawijaya · doi:10.21776/ub.jkb.2020.031.01.12 · Cited by 2
“Hepcidin is produced by fetal liver acts as a negative regulator of iron absorption from the placenta (45).”
BackgroundErythropoietin Concentration in Boys With p.His63Asp Polymorphism of the HFE Gene
Kaczorowska-Hac, B., Łuszczyk, M., Wasilewska, E., Antosiewicz, J., & Kaczor, J. J. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002126 · Cited by 2
Enfeksiyon Hastalıklarında Ferroptozun Rolü
Işkın, A. E., & Budak, F. (2023) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1337979 · Cited by 2
Toutou, M. M. M. (2024) · Egyptian Journal of Aquatic Biology and Fisheries · doi:10.21608/ejabf.2024.361014 · Cited by 2
Differential diagnosis of anemia in pregnant women
Prokhorenko, T. S., Zima, A. P., Саприна, Т. В., Мусина, Н. Н., Shakhmanova, N. S., & Novitsky, V. V. (2017) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2017-1-140-151 · Cited by 3
Is iron deficiency involved in the pathogenesis of chronic inflammatory skin disorders?
Ponikowska, M., & Szepietowski, J. C. (2019) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0013.3450 · Cited by 2
Hepsidin Sebagai Biomarker Anemia Pada Ibu Hamil
Pasalina, P. E., & Faisal, A. D. (2021) · Jurnal Kesehatan · doi:10.35730/jk.v11i3.707 · Cited by 2
Kamel, A. A., Elnaggar, M., Hamad, D. A., Zakhary, M. M., & Bakkar, S. M. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.273057 · Cited by 2
“It may easily combine with nearby biological molecules to cause considerable harm ((30)).”
BackgroundKumar, U., Masuma, S., Roopesh, L., Gowtham, C., & Himani, K. (2024) · Jabirian Journal of Biointerface Research in Pharmaceutics and Applied Chemistry · doi:10.55559/jjbrpac.v1i5.205 · Cited by 2
“[11,12] During iron deficiency states, hepcidin level falls and iron transport and absorption increases.”
Shen, Y., Li, D., Chen, Q., Wang, C., & Yu, L. (2025) · All Life · doi:10.1080/26895293.2025.2595807 · Cited by 1
Han, X., Guo, X. L., & Qiu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1762013 · Cited by 1
“Hepcidin is a core regulatory factor of systemic and local iron homeostasis, primarily through binding to the iron export protein ferroportin, inducing its endocytosis and degradation, thereby limiting iron ef fl ux and affecting the intracellular free iron pool (122).”
Iron Compartmentalisation and Vascular Endothelial Cell Dysfunction
Issitt, T., Kagugbe, G. W., Toe, Q. K., Wort, S. J., & Quinlan, G. J. (2026) · Antioxidants · doi:10.3390/antiox15060757 · Cited by 1
“First isolated and described as an antimicrobial peptide identified in the liver, hepcidin is now recognised as the primary regulator of global iron homeostasis [30].”
Niedobór żelaza bez niedokrwistości u dzieci: aktualny stan wiedzy
Chmielewska, A., & Dryl, R. (2015) · Pediatria Polska · doi:10.1016/j.pepo.2015.10.008 · Cited by 1
Matriptase-2 links erythropoietin to iron
Bartnikas, T. B. (2016) · Blood · doi:10.1182/blood-2016-02-694919 · Cited by 1
“Themeans bywhich erythropoiesis impacts iron metabolism has perplexed researchers for decades.(3) The discovery of hepcidin as a central regulator of iron metabolism and the demonstration that EPO inhibits hepcidin expression permits a refocusing of this question at a molecular level: How does EPO regulate hepcidin ex…”
BackgroundPocket-sized iron regulators: one size fits all?
Subramaniam, V. N. (2016) · Blood · doi:10.1182/blood-2016-05-716043 · Cited by 1
Self-citationYagob, T. (2016) · Research Repository (Delft University of Technology) · doi:10.4233/uuid:12fc9d70-990e-43f0-930e-96f9a1b2879d · Cited by 1
Grignano, É., Cantero-Aguilar, L., Tuerdi, Z., Chabane, T., Vazquez, R., Johnson, N., Birsen, R., Fontenay, M., Kosmider, O., Chapuis, N., et al. (2022) · theses.fr (ABES) · doi:10.70675/a407bc1bz71acz48a0z839bz2244f6473e53 · Cited by 2
Drug Repurposing Patent Applications January–March 2016
Mucke, H. A. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2016.29042.pq1 · Cited by 1
Chmiel-Majewska, K., Daniewska, D., Żelek, T., & Gellert, R. (2015) · Postępy Nauk Medycznych · doi:10.5604/08606196.1189836
“Inflammation is another hepcidin transcriptional regulator, through the JAK-STAT3 pathway initiated by Il-6 (12, 13).”
BackgroundSerum Prohepcidin Levels in Children with Thalassemia Major and Intermedia
Yılmaz, C., Aral, Y. Z., Karul, A., & Kozacı, L. D. (2017) · Meandros Medical And Dental Journal · doi:10.4274/meandros.2478
Hemochromatosis and Iron Storage Disorders
Kowdley, K. V., & Handa, P. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch30
Metadata
- Authors
- Rishi, G., Wallace, D. F., & Subramaniam, V. N.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Rishi, Gautam
- Venue
- Bioscience Reports
- Publisher
- Portland Press Ltd.
- Published
- 2015-05-19
- Volume
- 35
- Issue
- 3
- ISSN
- 0144-8463 (ISSN-L)
- 1573-4935
- PMC
- PMC4438303
- OpenAlex
- W2139439041
- Cited by
- 223
- References
- 102
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 22 · 2022: 18 · 2021: 25 · 2020: 28 · 2019: 19 · 2018: 21 · 2017: 21 · 2016: 15 · 2015: 10
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Bioscience Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Faculty of Health; Institute of Health and Biomedical Innovation
- Funders
- Medical Research Council
- National Health and Medical Research Council (1024672)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- hepcidin, iron homeostasis, ferroportin, iron export, iron absorption, iron deficiency, iron overload, hemochromatosis, hypoxia, inflammation, erythropoiesis, signaling pathways
- MeSH terms
- Ferroportin, Animals, Erythropoietin, Hemochromatosis, Humans, Inflammation, Iron, Transferrin, Signal Transduction, Cell Hypoxia, Bone Morphogenetic Proteins, Cation Transport Proteins, Mice, Smad Proteins, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.